Global Rheumatoid Arthritis Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Rheumatoid Arthritis Therapeutics estimated at US$ 7504.7 million in the year 2022, is projected to reach a revised size of US$ 9023 million by 2028, growing at a CAGR of 3.1% during the forecast period 2022-2028.

The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Rheumatoid Arthritis Therapeutics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Rheumatoid Arthritis Therapeutics market. Further, it explains the major drivers and regional dynamics of the global Rheumatoid Arthritis Therapeutics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Sanofi

Pfizer

Roche

Johnson & Johnson

AbbVie

Eli Lilly

Amgen

Sobi

Bristol-Myers Squibb

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Symptomatic Treatment

Intermediate Corticosteroid Therapies

Disease Modifying Antirheumatic Drug Therapies

Hospital Pharmacy

Retail Pharmacy

Drug Stores

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Rheumatoid Arthritis Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Rheumatoid Arthritis Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Rheumatoid Arthritis Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Rheumatoid Arthritis Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rheumatoid Arthritis Therapeutics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Rheumatoid Arthritis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Rheumatoid Arthritis Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi, Pfizer, Roche, Johnson & Johnson, AbbVie, Eli Lilly, Amgen, Sobi and Bristol-Myers Squibb, etc.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rheumatoid Arthritis Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Symptomatic Treatment

1.2.3 Intermediate Corticosteroid Therapies

1.2.4 Disease Modifying Antirheumatic Drug Therapies

1.3 Market by Application

1.3.1 Global Rheumatoid Arthritis Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Drug Stores

1.4 Study Objectives

1.5 Years Considered

2.1 Global Rheumatoid Arthritis Therapeutics Market Size (2017-2028)

2.2 Rheumatoid Arthritis Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Rheumatoid Arthritis Therapeutics Market Size by Region (2017-2022)

2.4 Global Rheumatoid Arthritis Therapeutics Market Size Forecast by Region (2023-2028)

2.5 Global Top Rheumatoid Arthritis Therapeutics Countries Ranking by Market Size

3.1 Global Rheumatoid Arthritis Therapeutics Revenue by Players

3.1.1 Global Rheumatoid Arthritis Therapeutics Revenue by Players (2017-2022)

3.1.2 Global Rheumatoid Arthritis Therapeutics Market Share by Players (2017-2022)

3.2 Global Rheumatoid Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Rheumatoid Arthritis Therapeutics Revenue

3.4 Global Rheumatoid Arthritis Therapeutics Market Concentration Ratio

3.4.1 Global Rheumatoid Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rheumatoid Arthritis Therapeutics Revenue in 2021

3.5 Global Rheumatoid Arthritis Therapeutics Key Players Head office and Area Served

3.6 Key Players Rheumatoid Arthritis Therapeutics Product Solution and Service

3.7 Date of Enter into Rheumatoid Arthritis Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Rheumatoid Arthritis Therapeutics Historic Revenue by Type (2017-2022)

4.2 Global Rheumatoid Arthritis Therapeutics Forecasted Revenue by Type (2023-2028)

5.1 Global Rheumatoid Arthritis Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Application (2023-2028)

6.1 North America Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022)

6.2 North America Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2028)

6.3 North America Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2028)

6.4 North America Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7.1 Europe Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022)

7.2 Europe Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2028)

7.3 Europe Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2028)

7.4 Europe Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8.1 Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022)

8.2 Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2028)

8.3 Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2028)

8.4 Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9.1 Latin America Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022)

9.2 Latin America Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2028)

9.3 Latin America Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2028)

9.4 Latin America Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10.1 Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022)

10.2 Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2028)

10.3 Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2028)

10.4 Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 U.A.E

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Rheumatoid Arthritis Therapeutics Products and Services

11.1.4 Sanofi Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.1.5 Sanofi Rheumatoid Arthritis Therapeutics SWOT Analysis

11.1.6 Sanofi Recent Developments

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Rheumatoid Arthritis Therapeutics Products and Services

11.2.4 Pfizer Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.2.5 Pfizer Rheumatoid Arthritis Therapeutics SWOT Analysis

11.2.6 Pfizer Recent Developments

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Rheumatoid Arthritis Therapeutics Products and Services

11.3.4 Roche Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.3.5 Roche Rheumatoid Arthritis Therapeutics SWOT Analysis

11.3.6 Roche Recent Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Rheumatoid Arthritis Therapeutics Products and Services

11.4.4 Johnson & Johnson Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.4.5 Johnson & Johnson Rheumatoid Arthritis Therapeutics SWOT Analysis

11.4.6 Johnson & Johnson Recent Developments

11.5 AbbVie

11.5.1 AbbVie Company Details

11.5.2 AbbVie Business Overview

11.5.3 AbbVie Rheumatoid Arthritis Therapeutics Products and Services

11.5.4 AbbVie Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.5.5 AbbVie Rheumatoid Arthritis Therapeutics SWOT Analysis

11.5.6 AbbVie Recent Developments

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Rheumatoid Arthritis Therapeutics Products and Services

11.6.4 Eli Lilly Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.6.5 Eli Lilly Rheumatoid Arthritis Therapeutics SWOT Analysis

11.6.6 Eli Lilly Recent Developments

11.7 Amgen

11.7.1 Amgen Company Details

11.7.2 Amgen Business Overview

11.7.3 Amgen Rheumatoid Arthritis Therapeutics Products and Services

11.7.4 Amgen Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.7.5 Amgen Rheumatoid Arthritis Therapeutics SWOT Analysis

11.7.6 Amgen Recent Developments

11.8 Sobi

11.8.1 Sobi Company Details

11.8.2 Sobi Business Overview

11.8.3 Sobi Rheumatoid Arthritis Therapeutics Products and Services

11.8.4 Sobi Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.8.5 Sobi Rheumatoid Arthritis Therapeutics SWOT Analysis

11.8.6 Sobi Recent Developments

11.9 Bristol-Myers Squibb

11.9.1 Bristol-Myers Squibb Company Details

11.9.2 Bristol-Myers Squibb Business Overview

11.9.3 Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics Products and Services

11.9.4 Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022)

11.9.5 Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics SWOT Analysis

11.9.6 Bristol-Myers Squibb Recent Developments

12.1 Rheumatoid Arthritis Therapeutics Market Trends

12.2 Rheumatoid Arthritis Therapeutics Market Drivers

12.3 Rheumatoid Arthritis Therapeutics Market Challenges

12.4 Rheumatoid Arthritis Therapeutics Market Restraints

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

List of Tables

    Table 1. Global Rheumatoid Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

    Table 2. Key Players of Symptomatic Treatment

    Table 3. Key Players of Intermediate Corticosteroid Therapies

    Table 4. Key Players of Disease Modifying Antirheumatic Drug Therapies

    Table 5. Global Rheumatoid Arthritis Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

    Table 6. Global Rheumatoid Arthritis Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

    Table 7. Global Rheumatoid Arthritis Therapeutics Revenue by Region (2017-2022) & (US$ Million)

    Table 8. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Region (2017-2022)

    Table 9. Global Rheumatoid Arthritis Therapeutics Revenue by Players (2017-2022) & (US$ Million)

    Table 10. Global Rheumatoid Arthritis Therapeutics Market Share by Players (2017-2022)

    Table 11. Global Top Rheumatoid Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Therapeutics as of 2021)

    Table 12. Ranking of Global Top Rheumatoid Arthritis Therapeutics Companies by Revenue (US$ Million) in 2021

    Table 13. Global 5 Largest Players Market Share by Rheumatoid Arthritis Therapeutics Revenue (CR5 and HHI) & (2017-2022)

    Table 14. Key Players Headquarters and Area Served

    Table 15. Key Players Rheumatoid Arthritis Therapeutics Product Solution and Service

    Table 16. Date of Key Manufacturers Enter into Rheumatoid Arthritis Therapeutics Market

    Table 17. Mergers & Acquisitions, Expansion Plans

    Table 18. Global Rheumatoid Arthritis Therapeutics Market Size by Type (2017-2022) & (US$ Million)

    Table 19. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2017-2022)

    Table 20. Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 21. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2023-2028)

    Table 22. Global Rheumatoid Arthritis Therapeutics Market Size by Application (2017-2022) & (US$ Million)

    Table 23. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2017-2022)

    Table 24. Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 25. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2023-2028)

    Table 26. North America Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 27. North America Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 28. North America Rheumatoid Arthritis Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 29. North America Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 30. North America Rheumatoid Arthritis Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 31. North America Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 32. North America Rheumatoid Arthritis Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 33. Europe Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 34. Europe Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 35. Europe Rheumatoid Arthritis Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 36. Europe Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 37. Europe Rheumatoid Arthritis Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 38. Europe Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 39. Europe Rheumatoid Arthritis Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 40. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 41. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 42. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 43. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 44. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 45. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Region (2017-2022) & (US$ Million)

    Table 46. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue by Region (2023-2028) & (US$ Million)

    Table 47. Latin America Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 48. Latin America Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 49. Latin America Rheumatoid Arthritis Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 50. Latin America Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 51. Latin America Rheumatoid Arthritis Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 52. Latin America Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 53. Latin America Rheumatoid Arthritis Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 54. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Company (2020-2022) & (US$ Million)

    Table 55. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Type (2017-2022) & (US$ Million)

    Table 56. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Type (2023-2028) & (US$ Million)

    Table 57. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Application (2017-2022) & (US$ Million)

    Table 58. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Application (2023-2028) & (US$ Million)

    Table 59. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Country (2017-2022) & (US$ Million)

    Table 60. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue by Country (2023-2028) & (US$ Million)

    Table 61. Sanofi Company Details

    Table 62. Sanofi Business Overview

    Table 63. Sanofi Rheumatoid Arthritis Therapeutics Product and Services

    Table 64. Sanofi Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 65. Sanofi Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 66. Sanofi Recent Developments

    Table 67. Pfizer Company Details

    Table 68. Pfizer Business Overview

    Table 69. Pfizer Rheumatoid Arthritis Therapeutics Product and Services

    Table 70. Pfizer Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 71. Pfizer Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 72. Pfizer Recent Developments

    Table 73. Roche Company Details

    Table 74. Roche Business Overview

    Table 75. Roche Rheumatoid Arthritis Therapeutics Product and Services

    Table 76. Roche Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 77. Roche Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 78. Roche Recent Developments

    Table 79. Johnson & Johnson Company Details

    Table 80. Johnson & Johnson Business Overview

    Table 81. Johnson & Johnson Rheumatoid Arthritis Therapeutics Product and Services

    Table 82. Johnson & Johnson Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 83. Johnson & Johnson Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 84. Johnson & Johnson Recent Developments

    Table 85. AbbVie Company Details

    Table 86. AbbVie Business Overview

    Table 87. AbbVie Rheumatoid Arthritis Therapeutics Product and Services

    Table 88. AbbVie Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 89. AbbVie Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 90. AbbVie Recent Developments

    Table 91. Eli Lilly Company Details

    Table 92. Eli Lilly Business Overview

    Table 93. Eli Lilly Rheumatoid Arthritis Therapeutics Product and Services

    Table 94. Eli Lilly Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 95. Eli Lilly Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 96. Eli Lilly Recent Developments

    Table 97. Amgen Company Details

    Table 98. Amgen Business Overview

    Table 99. Amgen Rheumatoid Arthritis Therapeutics Product and Services

    Table 100. Amgen Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 101. Amgen Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 102. Amgen Recent Developments

    Table 103. Sobi Company Details

    Table 104. Sobi Business Overview

    Table 105. Sobi Rheumatoid Arthritis Therapeutics Product and Services

    Table 106. Sobi Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 107. Sobi Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 108. Sobi Recent Developments

    Table 109. Bristol-Myers Squibb Company Details

    Table 110. Bristol-Myers Squibb Business Overview

    Table 111. Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics Product and Services

    Table 112. Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics Revenue in Rheumatoid Arthritis Therapeutics Business (2017-2022) & (US$ Million)

    Table 113. Bristol-Myers Squibb Rheumatoid Arthritis Therapeutics SWOT Analysis

    Table 114. Bristol-Myers Squibb Recent Developments

    Table 115. Rheumatoid Arthritis Therapeutics Market Trends

    Table 116. Rheumatoid Arthritis Therapeutics Market Drivers

    Table 117. Rheumatoid Arthritis Therapeutics Market Challenges

    Table 118. Rheumatoid Arthritis Therapeutics Market Restraints

    Table 119. Research Programs/Design for This Report

    Table 120. Key Data Information from Secondary Sources

    Table 121. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Rheumatoid Arthritis Therapeutics Sales Market Share by Type: 2021 VS 2028

    Figure 2. Symptomatic Treatment Features

    Figure 3. Intermediate Corticosteroid Therapies Features

    Figure 4. Disease Modifying Antirheumatic Drug Therapies Features

    Figure 5. Global Rheumatoid Arthritis Therapeutics Sales Market Share by Application: 2021 VS 2028

    Figure 6. Hospital Pharmacy Case Studies

    Figure 7. Retail Pharmacy Case Studies

    Figure 8. Drug Stores Case Studies

    Figure 9. Rheumatoid Arthritis Therapeutics Report Years Considered

    Figure 10. Global Rheumatoid Arthritis Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 11. Global Rheumatoid Arthritis Therapeutics Market Size 2017-2028 (US$ Million)

    Figure 12. Global Rheumatoid Arthritis Therapeutics Market Size Market Share by Region: 2021 VS 2028

    Figure 13. Global Rheumatoid Arthritis Therapeutics Revenue Market Share by Region in 2017 VS 2022

    Figure 14. Global Top 10 Rheumatoid Arthritis Therapeutics Countries Ranking by Market Size (US$ Million) in 2021

    Figure 15. Global Rheumatoid Arthritis Therapeutics Market Share by Players in 2021

    Figure 16. Global Top Rheumatoid Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Therapeutics as of 2021)

    Figure 17. The Top 10 and 5 Players Market Share by Rheumatoid Arthritis Therapeutics Revenue in 2021

    Figure 18. North America Rheumatoid Arthritis Therapeutics Revenue Market Share by Company in 2021

    Figure 19. North America Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 20. North America Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 21. North America Rheumatoid Arthritis Therapeutics Revenue Share by Country (2017-2028)

    Figure 22. U.S. Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 23. Canada Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 24. Europe Rheumatoid Arthritis Therapeutics Revenue Market Share by Company in 2021

    Figure 25. Europe Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 26. Europe Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 27. Europe Rheumatoid Arthritis Therapeutics Revenue Share by Country (2017-2028)

    Figure 28. Germany Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 29. France Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 30. U.K. Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 31. Italy Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 32. Russia Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 33. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue Market Share by Company in 2021

    Figure 34. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 35. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 36. Asia Pacific Rheumatoid Arthritis Therapeutics Revenue Share by Region (2017-2028)

    Figure 37. China Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 38. Japan Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 39. South Korea Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 40. India Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 41. Australia Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 42. Taiwan Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 43. Indonesia Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 44. Thailand Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 45. Malaysia Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 46. Philippines Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 47. Vietnam Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 48. Latin America Rheumatoid Arthritis Therapeutics Revenue Market Share by Company in 2021

    Figure 49. Latin America Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 50. Latin America Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 51. Latin America Rheumatoid Arthritis Therapeutics Revenue Share by Country (2017-2028)

    Figure 52. Mexico Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 53. Brazil Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 54. Argentina Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 55. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue Market Share by Company in 2021

    Figure 56. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue Market Share by Type (2017-2028)

    Figure 57. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue Market Share by Application (2017-2028)

    Figure 58. Middle East and Africa Rheumatoid Arthritis Therapeutics Revenue Share by Country (2017-2028)

    Figure 59. Turkey Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 60. Saudi Arabia Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 61. U.A.E Rheumatoid Arthritis Therapeutics Revenue (2017-2028) & (US$ Million)

    Figure 62. Sanofi Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 63. Pfizer Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 64. Roche Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 65. Johnson & Johnson Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 66. AbbVie Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 67. Eli Lilly Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 68. Amgen Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 69. Sobi Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 70. Bristol-Myers Squibb Revenue Growth Rate in Rheumatoid Arthritis Therapeutics Business (2017-2022)

    Figure 71. Bottom-up and Top-down Approaches for This Report

    Figure 72. Data Triangulation

    Figure 73. Key Executives Interviewed